These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5919803)

  • 1. Comparative research on the fibrinolytic action of different nicotinic acid derivatives following their prolonged administration into rabbits.
    De Nicola P; Gibelli A; Turazza G
    Thromb Diath Haemorrh; 1966 Jan; 15(1):231-7. PubMed ID: 5919803
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and experimental research on prolonged fibrinolytic treatment. 2. Activation of fibrinolysis by prolonged administration of nicotinic acid derivatives].
    De Nicola P; Gibelli A; Frandoli G; Turazza G
    Hemostase; 1965 Dec; 5(4):343-51. PubMed ID: 5880346
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nicotinic acid and fibrinolysis in humans. I. Regional fibrinolysis (cerebral, of the upper extremity and of the lower extremity) caused by "arterial" administration of nicotinic acid].
    Tesi M
    Riv Crit Clin Med; 1967 Dec; 67(6):465-83. PubMed ID: 5603691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nicotinic acid level in the blood and fibrinolysis under the influence of hexanicotinic acid esters of m-inositol].
    Sommer H
    Arzneimittelforschung; 1965 Nov; 15(11):1337-9. PubMed ID: 5340070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the coagulation and anti-coagulation systems of the blood under the influence of nicotinic acid].
    Kiseleva LN; Romanenko GK
    Klin Med (Mosk); 1966 Jan; 44(1):48-50. PubMed ID: 5988141
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action mechanism of nicotinic acid on fibrinolysis in vitro and in vivo].
    Andreenko GV; Migalina LA
    Vopr Med Khim; 1971; 17(4):423-7. PubMed ID: 5317629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged fibrinolytic prophylactic treatment with nicotinic acid derivatives and MAO-inhibitors.
    De Nicola P
    Thromb Diath Haemorrh Suppl; 1966; 20():289-95. PubMed ID: 5298378
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinogen turnover during the treatment with xantinol nicotinate.
    Cultrera G; Giarola P; Gibelli A; Baldoni E; Cuttin S; Galetti G; Serenth'a P
    Arzneimittelforschung; 1971 Jul; 21(7):954-7. PubMed ID: 5109508
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G; Spreafico PL; Frandoli G
    Arzneimittelforschung; 1973 May; 23(5):654-7. PubMed ID: 4575777
    [No Abstract]   [Full Text] [Related]  

  • 11. [On activation of fibrinolysis in vitro and in vivo by nicotinic acid, heparin and their mixtures].
    Goossens N
    Med Welt; 1967 Apr; 14():899-903. PubMed ID: 4869469
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of epsilon-aminocaproic acid and of parotid inhibitor on the fibrinolysis activation due to nicotinic acid derivatives and to heparin-like substances.
    Gibelli A; Turazza G; Giarola P; De Nicola P
    Farmaco Sci; 1966 Apr; 21(4):301-9. PubMed ID: 4160699
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology and pharmacokinetics of nicotinic acid.
    Weiner M
    Drug Metab Rev; 1979; 9(1):99-106. PubMed ID: 376259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary study of the tolerance of 3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate (I. 612) and on its effects on plasma lipid pattern, hemostasis and clotting-fibrinolysis balance].
    Buzzelli G; Doni A; Lippi G; Resina A
    Clin Ter; 1979 May; 89(3):251-66. PubMed ID: 466976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrinolytic action of Complamin (R). Preliminary report].
    Harel P; Gauthier J
    Union Med Can; 1966 May; 95(5):542-5. PubMed ID: 5932651
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of Trasylol on blood coagulation and fibrinolysis after intravenous injection.
    Gormsen J
    Acta Chir Scand Suppl; 1967; 378():53-61. PubMed ID: 4966132
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of thrombophilic states by prolonged activation of fibrinolysis].
    De Nicola P
    Rev Atheroscler (Paris); 1967; 9(3):20-2. PubMed ID: 4174225
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of xanthinol niacinate on blood coagulation].
    Balkuv S; Akman N; Ulutin ON
    Turk Tip Cemiy Mecm; 1966 Dec; 32(12):711-4. PubMed ID: 5976287
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electron microscope studies of thrombocytes of rabbits before and after administration of epsilon-aminocaproic acid].
    Beznosikova VK; Chaplygina ZA; Beznosikov BO
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):32-7. PubMed ID: 5736821
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of nicotinic acid on fibrinolytic activity in health, in thrombotic disease and in liver cirrhosis.
    Robertson BR
    Acta Chir Scand; 1971; 137(7):643-8. PubMed ID: 5149150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.